Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

37 ta ish

Ish: Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase

  1. Syrian Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expressed in Escherichia coli: Production of Homogeneous Protein

    Kenneth Frimpong, Bryant G. Darnay, V.W. Rodwell

    Maqola19934 iqtibos
    ABI

  2. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

    F. William Studier, Barbara A. Moffatt

    Maqola19864 iqtibos
    ABI

  3. Biomedical applications of dipeptides and tripeptides

    Sara Santos, Inês M. Torcato, Miguel A. R. B. Castanho

    Sharh maqola20124 iqtibos
    ABI

  4. Structure-Based Drug Design: Docking and Scoring

    Romano T. Kroemer

    Sharh maqola20074 iqtibos
    ABI

  5. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

    Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

    Maqola20184 iqtibos
    ABI

  6. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

    Selami Ercan, Ercan Çınar, Cihat Özaydın +2

    Maqola20204 iqtibos
    ABI

  7. Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials

    Prakash Deedwania, Vibhuti Singh, Michael H. Davidson

    Maqola20093 iqtibos
    ABI

  8. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management

    Arturo Zárate, Leticia Manuel‐Apolinar, Renata Saucedo +2

    Sharh maqola20163 iqtibos
    ABI

  9. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes

    Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar +1

    Sharh maqola20183 iqtibos
    ABI

  10. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients

    L. Masana, Alberto Zamora, Núria Plana +9

    Maqola20193 iqtibos
    ABI

  11. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert, J. Michael Gaziano, Ki Sau Chan +1

    Maqola19982 iqtibos
    ABI

  12. Sarlavhasiz

    Boshqa1 iqtibos
    ABI